en

PRODUCT DETAIL

MAVENCLAD 10 mg tablety

Code 5106C
MA number EU/1/17/1212/005
Product Form: tbl 7x10 mg (blis.Al/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA40 Cladribine
Shelf life: 48
Container: blister Al/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 22.08.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 04.05.2022
eu-flag.png sk-flag.png